Animal coagulation time determination is a fundamental laboratory experiment used to evaluate the hemocompatibility of blood-contacting medical devices and to assess the procoagulant or anticoagulant activity of pharmaceutical compounds in animal models. This technical article reviews the testing principles, animal models, experimental methods, and applicable standards such as ISO 10993-4 and GB/T 16886.4 commonly followed by accredited third-party laboratories.
Technical Overview
Animal coagulation time determination is an in vitro or in vivo experiment that measures the time required for freshly drawn animal blood to transition from a liquid state to a stable fibrin clot. The test reflects the functional integrity of the intrinsic coagulation pathway and serves as a sensitive indicator of blood–material interactions. In the context of medical device biological evaluation, the experiment is a core component of thrombosis and coagulation assessment under the hemocompatibility framework of ISO 10993-4 and its Chinese counterpart GB/T 16886.4.
The experiment typically involves exposing whole blood or platelet-rich plasma from laboratory animals—most commonly rabbits, rats, mice, dogs, or swine—to a test material or a candidate compound, followed by timed observation of clot formation. Prolongation of coagulation time suggests anticoagulant or material-mediated inhibition of the clotting cascade, while shortening may indicate thrombogenic potential. Because coagulation kinetics are highly sensitive to collection technique, temperature, and handling conditions, the experiment must be performed under strictly standardized protocols by experienced personnel in accredited third-party laboratories or qualified research facilities.
Animal welfare requirements are governed by ISO 10993-2 and GB/T 16886.2, which mandate the principles of replacement, reduction, and refinement (the 3Rs) in all animal testing programs.
Testing Samples
Blood-Contacting Medical Devices
Devices intended for direct or indirect contact with circulating blood are the primary category of samples submitted for coagulation time determination, including intravascular catheters, vascular grafts, stents, hemodialysisers, extracorporeal circulation tubing, blood oxygenators, blood bags, and infusion sets. Testing may be conducted on the intact device, material coupons, or device extracts depending on the intended clinical use and surface area considerations.
Biomaterials and Surface Coatings
Polymeric, metallic, and ceramic biomaterials, as well as antithrombotic surface coatings such as heparinized or hydrophilic treatments, are evaluated to characterize how surface chemistry influences clotting behavior in comparison with reference materials.
Pharmaceutical and Biological Products
Anticoagulant drugs, procoagulant agents, hemostatic devices, traditional herbal preparations, and nanomaterials are frequently tested in animal models to characterize their pharmacodynamic effects on the coagulation system prior to clinical studies.
Control Materials
Each experiment includes a negative control material with established blood compatibility, such as medical-grade polyethylene or glass depending on the study design, and may include a positive control known to activate coagulation, ensuring the sensitivity and validity of the test system.
Testing Items
Depending on the study objective, the animal coagulation time determination experiment may encompass the following measurement endpoints:
- Whole blood clotting time (Lee-White test tube method)
- Activated clotting time (ACT) using celite or kaolin activators
- Activated partial thromboplastin time (APTT) for the intrinsic pathway
- Prothrombin time (PT) for the extrinsic and common pathways
- Thrombin time (TT) for fibrin formation evaluation
- Plasma recalcification time for citrated blood systems
- Clot observation parameters, including clot morphology, weight, and degree of thrombus adhesion
Testing Methods
Test Tube Method (Lee-White Method)
Fresh non-anticoagulated blood is drawn from the animal and immediately dispensed into clean glass or material-contact test tubes maintained at 37 °C. The tubes are tilted at defined intervals until blood no longer flows when inverted, and the elapsed time is recorded as the coagulation time. This classical method is simple, economical, and well suited to material screening studies.
Silicone Tube Method
Slide Method
A drop of freshly collected blood is placed on a clean glass slide held at 37 °C, and the time until a fibrin thread or gel formation appears is recorded. The method requires only a minimal blood volume and is suitable for small rodent studies, though it carries greater operator variability.
Activated Clotting Time Method
Whole blood is mixed with a contact activator such as celite or kaolin, and clot formation is detected either visually or by an automated coagulometer. The accelerated reaction improves reproducibility and is particularly useful for evaluating extracorporeal circuit materials and anticoagulant dosing studies.
General Test Procedure
- Animal acclimatization and health verification, including baseline coagulation screening where required
- Randomization of animals into treatment, negative control, and positive control groups
- Blood collection by an approved route, typically venipuncture or cardiac puncture under anesthesia, with minimal tissue trauma and rapid transfer to the test system
- Exposure of blood to the test material, extract, or compound at 37 °C under controlled contact conditions
- Timed endpoint determination of clot formation and recording of replicate measurements
- Statistical comparison of mean coagulation times between groups with appropriate significance testing
Quality Control and Result Interpretation
Critical variables include strict maintenance of 37 °C temperature, avoidance of hemolysis, consistent tube dimensions, standardized tilt technique, and completion of all measurements within the physiologically valid time window after blood draw. A statistically significant prolongation of coagulation time indicates anticoagulant activity, whereas significant shortening indicates thrombogenic potential. Results should always be interpreted alongside complementary hemocompatibility assays such as thrombosis testing, platelet counting, hemolysis testing, and complement activation.
Applications
Animal coagulation time determination experiments support a wide range of scientific and regulatory applications:
- Regulatory biocompatibility evaluation of blood-contacting medical devices for registration submissions
- Research and development screening of antithrombotic biomaterials and surface modification technologies
- Pharmacodynamic and safety assessment of anticoagulant, procoagulant, and hemostatic drug candidates
- Evaluation of traditional herbal medicines and functional ingredients for effects on the coagulation system
- Academic research on hemostasis mechanisms, thrombosis models, and genetic coagulation disorders
- Preclinical toxicology studies in which altered coagulation time serves as a safety biomarker
FAQ
Which animal species are most commonly used?
Rabbits and rats are the most frequently used species due to adequate blood volume, well-characterized coagulation profiles, and regulatory acceptance. Mice are used when volume requirements are minimal, while dogs, swine, and sheep are preferred when larger blood volumes or cardiovascular physiology closer to humans is required.
How much blood volume does the experiment require?
The Lee-White tube method typically requires approximately 1 mL per tube, the slide method requires only a few drops, and instrument-based ACT or APTT methods generally require 0.5–2 mL per measurement. Total volume must remain within approved animal welfare limits for the species and body weight.
What is the typical turnaround time?
For a standard in vitro screening study with a documented protocol, the experimental phase is usually completed within one to two weeks, while full studies including protocol approval, animal acclimatization, and reporting generally require three to six weeks depending on study complexity.
Which factors most commonly affect test results?
Key variables include sample collection technique, temperature control, time delay before testing, tube surface properties, animal stress levels, circadian rhythms, diet, and any pre-existing medications. Standardization of these variables is essential for reproducible and defensible results.
How is animal welfare ensured during the experiment?
All procedures must comply with ISO 10993-2 and GB/T 16886.2, be reviewed and approved by an institutional animal care and use committee, be performed by trained personnel, and apply anesthesia and analgesia as appropriate to minimize pain and distress throughout the study.
Can coagulation time testing replace full hemocompatibility evaluation?
No. Coagulation time determination is one element of the thrombosis and coagulation category defined in ISO 10993-4. A complete hemocompatibility assessment should also consider thrombosis, platelet function, hematology, complement activation, and hemolysis endpoints based on the device's blood contact category and contact duration.